Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Higher dose of gefapixant hits endpoints in chronic cough trial

pharmatimesMarch 19, 2020

Tag: gefapixant , chronic cough , msd

PharmaSources Customer Service